GPT Healthcare Ltd stands as one of the prominent regional healthcare companies in Eastern India, operating a comprehensive network of multi-specialty hospitals under the renowned ILS Hospitals brand. Incorporated in 1989, GPT Healthcare Ltd is engaged in running hospitals and providing medical services and has evolved into a significant player in the healthcare sector with a strong presence across multiple states.
The company was formerly established as "Jibansatya Printing House Private Limited" on August 17, 1989, at Kolkata, West Bengal. The name of the Company was changed to "GPT Healthcare Private Limited" on March 31, 2005. Thereafter, the Company converted to a Public Company, and the name was changed to "GPT Healthcare Limited." A fresh Certificate of Incorporation was issued on September 15, 2021, consequent upon the change in name to a Limited Company.
GPTHL has established NABH & NABL accredited Right Sized and Full Service 4 Multi-speciality Hospitals by the name of ILS Salt Lake, ILS Agartala, ILS Dum Dum, and ILS Howrah. The company's infrastructure is substantial, with these hospitals having a total capacity of 561 Beds, 90 Full-time consultants, and 560 Visiting consultants. GPT Healthcare, the healthcare arm of the GPT Group, currently owns and operates over 561 beds spread across four state-of-the-art multi-specialty hospitals in the eastern part of the country under the brand name ILS Hospitals.
The company offers a comprehensive range of healthcare services, including:
- Internal medicine and diabetology
- Nephrology (such as renal transplants)
- Laparoscopic and general surgery
- Gynecology and obstetrics
- Critical care
- Gastroenterology
- Orthopedics and joint replacement
- Interventional cardiology
- Neurosciences
- Pediatrics
- Diagnostic services
- Neonatology
It also operates pharmacies, providing a comprehensive healthcare ecosystem to its patients.
The market cap of GPT Healthcare Ltd (GPTHEALTH) is ₹1,442.77 Cr as of July 14, 2025. The company's financial metrics present a mixed picture with a P/E (price-to-earnings) ratio of 28.90 and a P/B (price-to-book) ratio of 6.60.
Recent financial performance shows resilience. Net profit of GPT Healthcare rose 0.55% to Rs 12.89 crore in the quarter ended March 2025 as against Rs 12.82 crore during the previous quarter ended March 2024. Sales rose 1.98% to Rs 101.40 crore in the quarter ended March 2025 as against Rs 99.43 crore during the previous quarter ended March 2024.
For the full year FY25, net profit rose 4.50% to Rs 49.92 crore in the year ended March 2025 as against Rs 47.77 crore during the previous year ended March 2024. Sales rose 1.72% to Rs 407.09 crore in the year ended March 2025 as against Rs 400.19 crore during the previous year ended March 2024.
- Market Capitalization: ₹1,442.77 Cr (as of July 14, 2025)
- P/E Ratio: 28.90
- P/B Ratio: 6.60
- Dividend Yield: 0.85%
- 52-Week High: ₹208.45
- 52-Week Low: ₹126.10
- Revenue FY25: ₹407.09 Cr
- Net Profit FY25: ₹49.92 Cr
- EBITDA Margin Q3FY25: 22.2%
- Promoter Holding: 65.57% (GPT Sons Private Limited)
The company is actively pursuing expansion plans with the aim to become a 1,000-bed hospital chain in the next 2-3 years. Their upcoming hospital in Raipur is on track and is expected to be commissioned in Q4FY25. Additionally, radiation oncology services have been commissioned in November this year for the Agartala Hospital.
Recent developments include the company entering into a Memorandum of Understanding (MoU) for the construction and finishing of a hospital building at Jamshedpur, Jharkhand, demonstrating its commitment to geographic expansion.
The promoter of GPT Healthcare Ltd is GPT Sons Private Limited. GPT Sons Private Limited owns 65.57 per cent of the total equity, indicating strong promoter confidence in the company's prospects.
The company maintains a healthy dividend policy. GPT Healthcare announced that the Board of Directors of the Company at its meeting held on May 23, 2025, inter alia, have recommended a final dividend of Rs 1.5 per equity Share (i.e., 15%), subject to the approval of the shareholders.
Recent corporate actions, such as the 36th AGM on August 5, 2025, the final dividend of ₹1.50/share, and director appointments and remuneration updates, reflect the company's commitment to regular shareholder engagement and transparent governance practices.
GPT Healthcare Ltd represents a solid investment opportunity in the healthcare sector, particularly for investors seeking exposure to the growing healthcare market in Eastern India. With its established hospital network, consistent financial performance, and strategic expansion plans, the company is well-positioned to capitalize on the increasing demand for quality healthcare services in underserved regions.
